Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial

References

• [AIRE] Acute Infarction Ramipril Efficacy (AIRE) Study InvestigatorsEffect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study InvestigatorsLancet199334282188104270
   PubMed Web of Science ®Google Scholar
• AnderssonBAbergJLindelowBDose-related effects of metoprolol on heart rate and pharmacokinetics in heart failureJ Card Fail200173111711782853
   PubMed Web of Science ®Google Scholar
• AndrekaPAiyarNOlsonLCBucindolol displays intrinsic sympathomimetic activity in human myocardiumCirculation200210524293412021232
   PubMed Web of Science ®Google Scholar
• ArumanayagamMChanSTongSAntioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trialJ Cardiovasc Pharmacol200137485411152373
   PubMed Web of Science ®Google Scholar
• BakrisGLFonsecaVKatholiREMetabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trialJAMA200429222273615536109
   PubMed Web of Science ®Google Scholar
• [BEST] Beta-Blocker Evaluation of Survival Trial InvestigatorsA trial of the beta-blocker bucindolol in patients with advanced chronic heart failureN Engl J Med200134416596711386264
   PubMed Web of Science ®Google Scholar
• BristowMRChanges in myocardial and vascular receptors in heart failureJ Am Coll Cardiol1993224 Suppl A61A71A
   PubMed Web of Science ®Google Scholar
• BristowMRMechanism of action of beta-blocking agents in heart failureAm J Cardiol19978026L40L
   PubMed Web of Science ®Google Scholar
• BristowMRBeta-adrenergic receptor blockade in chronic heart failureCirculation20001015586910662755
   PubMed Web of Science ®Google Scholar
• BristowMRAbrahamWTYoshikawaTSecond- and third-generation beta-blocking drugs in chronic heart failureCardiovasc Drugs Ther199711Suppl 129169211023
   PubMedGoogle Scholar
• BristowMRGinsburgRUmansVBeta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failureCirc Res1986592973092876788
   PubMed Web of Science ®Google Scholar
• BristowMRKrause-SteinraufHNuzzoREffect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trialCirculation200411014374215337700
   PubMed Web of Science ®Google Scholar
• BristowMRMinobeWRasmussenRAlpha-1 adrenergic receptors in the nonfailing and failing human heartJ Pharmacol Exp Ther19882471039452849656
   PubMed Web of Science ®Google Scholar
• [CIBIS] Cardiac Insufficiency Bisoprolol Study IIThe Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialLancet199935391310023943
   PubMed Web of Science ®Google Scholar
• [CIBIS] CIBIS Investigators and CommitteesA randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and CommitteesCirculation1994901765737923660
   PubMed Web of Science ®Google Scholar
• CohnJNArchibaldDGZiescheSEffect of vasodialtor therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative studyN Engl J Med19863141547523520315
   PubMed Web of Science ®Google Scholar
• CommunalCSinghKSawyerDBOpposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G proteinCirculation199910022101210577992
   PubMed Web of Science ®Google Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• DargieHJEffect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trialLancet200135713859011356434
   PubMed Web of Science ®Google Scholar
• DiBiancoRParkerJOChakkoSDoxazosin for the treatment of chronic congestive heart failure: results of a randomized double-blind and placebo-controlled studyAm Heart J19911211 Pt 2372801670746
   PubMed Web of Science ®Google Scholar
• DornGW2ndAdrenergic pathways and left ventricular remodelingJ Card Fail200286 SupplS370312555147
   PubMed Web of Science ®Google Scholar
• GilbertEMAbrahamWTOlsenSComparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heartCirculation1996942817258941107
   PubMed Web of Science ®Google Scholar
• GiuglianoDAcamporaRMarfellaRMetabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trialAnn Intern Med199712695599182472
   PubMed Web of Science ®Google Scholar
• GreenbergBNonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European TrialRev Cardiovasc Med20045Suppl 1S101715184835
   PubMedGoogle Scholar
• HeilbrunnSMShahPBristowMRIncreased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathyCirculation198979483902537158
   PubMed Web of Science ®Google Scholar
• HjalmarsonAElmfeldtDHerlitzJEffect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trialLancet1981282376116950
   PubMed Web of Science ®Google Scholar
• JacobSRettKWicklmayrMDifferential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol studyJ Hypertens199614489948761899
   PubMed Web of Science ®Google Scholar
• KhamssiMBroddeOEThe role of cardiac beta1- and beta2 adrenoceptor stimulation in heart failureJ Cardiovasc Pharmacol199016Suppl 5S133711527117
   PubMedGoogle Scholar
• KoberLTorp-PedersenCCarlsenJEA clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study GroupN Engl J Med1995333167067477219
   PubMed Web of Science ®Google Scholar
• KukinMLKalmanJManninoMCombined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failureAm J Cardiol199677486918629589
   PubMed Web of Science ®Google Scholar
• LindLLithellHDecreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemiaAm Heart J19931255 Pt 2149478480620
   PubMed Web of Science ®Google Scholar
• LowesBDGilbertEMAbrahamWTMyocardial gene expression in dilated cardiomyopathy treated with beta-blocking agentsN Engl J Med200234613576511986409
   PubMed Web of Science ®Google Scholar
• LyskoPGWebbCLGuJLA comparison of carvedilol and metoprolol antioxidant activities in vitroJ Cardiovasc Pharmacol2000362778110942172
   PubMed Web of Science ®Google Scholar
• MaackCBohmMVlaskinLPartial agonist activity of bucindolol is dependent on the activation state of the human beta1adrenergic receptorCirculation20031083485312847069
   PubMed Web of Science ®Google Scholar
• [MDC] Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study GroupLancet199835111801
   Web of Science ®Google Scholar
• [MERIT-HF] Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart FailureEffect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)Lancet19993532001710376614
   PubMed Web of Science ®Google Scholar
• MetraMCasLDdi LenardaABeta-blockers in heart failure: are pharmacological differences clinically important?Heart Fail Rev200491233015516860
   PubMed Web of Science ®Google Scholar
• OhlsteinEHArlethAJStorerBCarvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cellsJ Mol Cell Cardiol199830167739500873
   PubMed Web of Science ®Google Scholar
• PackerMDo beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trialJ Card Fail200394294314966782
   PubMed Web of Science ®Google Scholar
• PackerMBristowMRCohnJNThe effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study GroupN Engl J Med19963341349558614419
   PubMed Web of Science ®Google Scholar
• PackerMCoatsAJFowlerMBEffect of carvedilol on survival in severe chronic heart failureN Engl J Med20013441651811386263
   PubMed Web of Science ®Google Scholar
• PfefferMABraunwaldEmoyeLAEffect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsN Engl J Med1992327669771386652
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPASwedbergKClelandJGComparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialLancet200336271312853193
   PubMed Web of Science ®Google Scholar
• SandbergABlomqvistIJonssonUEPharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tabletsEur J Clin Pharmacol198833SupplS9143371395
   PubMedGoogle Scholar
• SmithRSWarrenDJEffect of acute oral beta adrenergic blockade on muscle blood flow in manCardiovasc Res19821620586125262
   PubMed Web of Science ®Google Scholar
• Torp-PedersenCClelandJGDi LenardaACarvedilol reduces the risk for new onset of diabetes related adverse events in heart failure compared to metoprolol: Results of the COMET study [abstract]JACC200545Suppl 1187A
   Google Scholar
• Torp-PedersenCPoole-WilsonPASwedbergKEffects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMETAm Heart J2005149370615846279
   PubMed Web of Science ®Google Scholar
• WaagsteinFBristowMRSwedbergKBeneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study GroupLancet1993342144167902479
   PubMed Web of Science ®Google Scholar
• WaagsteinFHjalmarsonAVarnauskasEEffect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathyBr Heart J1975371022361191416
   PubMedGoogle Scholar
• YoshikawaTPortJDAsanoKCardiac adrenergic receptor effects of carvedilolEur Heart J199617Suppl B8168733065
   PubMedGoogle Scholar
• YueTLChengHYLyskoPGCarvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavengerJ Pharmacol Exp Ther19922639281357162
   PubMed Web of Science ®Google Scholar
• [Xamoterol] Xamoterol in Severe Heart Failure Study GroupXamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study GroupLancet1990336161694945
   PubMedGoogle Scholar